SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer
Lecture Time
11:15 - 11:25
Speakers
- Vicky Makker (New York City, NY, United States of America)